| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/05/2002 | EP1210428A1 Pd-1, a receptor for b7-4, and uses therefor |
| 06/05/2002 | EP1210426A2 Polymorphisms in a klotho gene |
| 06/05/2002 | EP1210424A1 Novel b7-4 molecules and uses therefor |
| 06/05/2002 | EP1210422A2 Human abc2 transporter and uses thereof |
| 06/05/2002 | EP1210421A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 06/05/2002 | EP1210419A2 Human transmembrane proteins |
| 06/05/2002 | EP1210370A1 Human tumor necrosis factor receptor tr16 |
| 06/05/2002 | EP1210345A1 Oxazole ppar antagonists |
| 06/05/2002 | EP1210325A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 06/05/2002 | EP1210320A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 06/05/2002 | EP1210130A1 Solid wound healing formulations containing fibronectin |
| 06/05/2002 | EP1210121A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 06/05/2002 | EP1210118A2 Composition comprising a tramadol material and an anticonvulsant drug |
| 06/05/2002 | EP1210117A2 Compositons for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds |
| 06/05/2002 | EP1210116A2 Pharmaceutical combination for the treatment of viral infections containing a calcium channel blocker and a quinoline |
| 06/05/2002 | EP1210112A2 Vaccine against hbv and hpv |
| 06/05/2002 | EP1210109A2 Utilization of an aminopeptidase inhibitor |
| 06/05/2002 | EP1210108A2 Use of leptin in inhibition of endothelial cell proliferation |
| 06/05/2002 | EP1210106A2 Methods, compositions and kits for promoting recovery from damage to the central nervous system |
| 06/05/2002 | EP1210100A1 Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins |
| 06/05/2002 | EP1210099A1 Methods and compositions useful for modulation of angiogenesis using protein kinase raf and ras |
| 06/05/2002 | EP1210092A1 Calcium-containing structures and methods of making and using the same |
| 06/05/2002 | EP1210091A1 Heartburn treatment |
| 06/05/2002 | EP1210090A2 Use of chemical chelators as reversal agents for drug-induced neuromuscular block |
| 06/05/2002 | EP1210089A2 Oral combinations of hydroxocobalamin and folic acid |
| 06/05/2002 | EP1210083A2 Methods for the treatment of mental and vascular disorders |
| 06/05/2002 | EP1210082A2 Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions |
| 06/05/2002 | EP1210080A2 Use of monoamine oxidase inhibitors for the manufacture of drugs intended for the treatment of obesity |
| 06/05/2002 | EP1210076A2 Drug therapy of the restless leg syndrome |
| 06/05/2002 | EP1210075A1 Compositions and methods for modification of skin lipid content |
| 06/05/2002 | EP1210069A2 Large porous particles by spray-drying |
| 06/05/2002 | EP1210063A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 06/05/2002 | EP1137438B1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors |
| 06/05/2002 | EP1121112B1 Stable formoterol concentrate |
| 06/05/2002 | EP1109817B1 Phosphohalohydrins, method for making same and uses |
| 06/05/2002 | EP1021191B1 Tightening and/or reducing the size of body parts containing fat cells |
| 06/05/2002 | EP0951474B1 Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them |
| 06/05/2002 | EP0925308B1 Compositions and methods for treating infections using analogues of indolicidin |
| 06/05/2002 | EP0804182B1 Use of gabapentin in the treatment of anxiety and panic |
| 06/05/2002 | EP0788361B1 Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids |
| 06/05/2002 | EP0752851B1 Process for preparing a pharmaceutical formulation |
| 06/05/2002 | EP0741574B1 Oral dosage form containing colestipol as a carrier and acidic active substances and a process for producing the same |
| 06/05/2002 | CN1352686A Cytokine receptor chain |
| 06/05/2002 | CN1352565A Agent for treating visual cell function disorder |
| 06/05/2002 | CN1352563A Use of phyllanthus for targeted stimulation of the immune system |
| 06/05/2002 | CN1352561A Method for enhancing the efficacy of anti-tumor agents |
| 06/05/2002 | CN1352557A Compositions for improivng fertility |
| 06/05/2002 | CN1352556A Therapeutic use of melatonin |
| 06/05/2002 | CN1352551A Preparations for the application of anti-inflammatory agents |
| 06/05/2002 | CN1352530A Methods for lowering viscosity of glucomannan compositions |
| 06/05/2002 | CA2364211A1 Combination treatment for depression, anxiety and psychosis |
| 06/04/2002 | US6399826 Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain |
| 06/04/2002 | US6399762 Methods and compositions for diagnosing and treating chromosome -18p related disorders |
| 06/04/2002 | US6399745 Use of leptin antagonists for treating insulin resistance in type II diabetes |
| 06/04/2002 | US6399655 Method for the prophylactic treatment of cataracts |
| 06/04/2002 | US6399654 Biflavanoids and derivatives thereof as antiviral agents |
| 06/04/2002 | US6399647 Amide derivatives for antiangiogenic and/or antitumorigenic use |
| 06/04/2002 | US6399636 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease (copd), eosinophilic granuloma, psoriasis and septic shock, ulcerative colitis, crohn's disease, reperfusion injury of the myocardium and brain |
| 06/04/2002 | US6399629 Efflux pump inhibitors |
| 06/04/2002 | US6399608 Fluoxetine, paroxetine or sertraline with 1,2,4-triazolo (4,3-b)pyridazine derivative; nonsedating anxiolytic modulator of benzodiazepine binding site of gamma amino-butyric acid receptor; central nervous system |
| 06/04/2002 | US6399605 Ophthalmic composition comprising a beta -blocker |
| 06/04/2002 | US6399601 Antidiabetic agents; nervous system disorders; anticholesterol agents |
| 06/04/2002 | US6399593 Contraceptives |
| 06/04/2002 | US6399577 Central nervous system disorders |
| 06/04/2002 | US6399573 Interleukin-1 receptor antagonist beta (IL-1rabeta) |
| 06/04/2002 | US6399571 Polypeptides |
| 06/04/2002 | US6399328 Amino acid sequence; hybridization probes; amplification primers; anticarcinogenic agents; antitumor agents |
| 06/04/2002 | US6399314 Methods of detection of amyloidogenic proteins |
| 06/04/2002 | US6399312 Myostatin gene promoter and inhibition of activation thereof |
| 06/04/2002 | US6399114 Nutritional system for nervous system disorders |
| 06/04/2002 | US6399110 Glucose-containing preparation |
| 06/04/2002 | US6399108 Compositions and methods for the treatment of skin disorders |
| 06/04/2002 | US6399107 Use of inhibitors of gag synthesis for the treatment of corneal haze |
| 06/04/2002 | US6399093 Method and composition to treat musculoskeletal disorders |
| 06/04/2002 | US6399063 Monoclonal antibodies directed to the HER2 receptor |
| 06/04/2002 | US6399061 Monoclonal secreted by atcc deposit no. hb11388 and transfectoma tcae8 accorded atcc deposit no. 69119; parenteral injection |
| 05/30/2002 | WO2002042777A2 Modulation of the interaction between evh1 domains |
| 05/30/2002 | WO2002042765A1 Remedies for digestive functional disorder and screening method |
| 05/30/2002 | WO2002042462A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 05/30/2002 | WO2002042456A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | WO2002042455A2 Modifier of organelle metalbolism |
| 05/30/2002 | WO2002042445A2 Differentiated cells suitable for human therapy |
| 05/30/2002 | WO2002042444A2 Fungal gene cluster associated with pathogenesis |
| 05/30/2002 | WO2002042437A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/30/2002 | WO2002042436A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 05/30/2002 | WO2002042432A2 Epothilone resistant cell lines |
| 05/30/2002 | WO2002042332A2 Truncated cd200 |
| 05/30/2002 | WO2002042330A2 Cystoskeleton-associated proteins |
| 05/30/2002 | WO2002042328A2 Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon |
| 05/30/2002 | WO2002042321A2 Mixed fibrils |
| 05/30/2002 | WO2002042302A1 Novel sulfonamide-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042301A1 Novel pyridine-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042300A1 Novel carbamate-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042299A1 Novel lactame-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042298A1 Aminothiazoles and their use as adenosine receptor antagonists |
| 05/30/2002 | WO2002042292A2 Indol derivative and their use as inhibitors of p38 kinase |
| 05/30/2002 | WO2002042278A2 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | WO2002042276A1 Quarternary proforms of tertiary amine containing compounds |
| 05/30/2002 | WO2002042273A2 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | WO2002042272A2 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |